GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,320,000 | +7274.0% | 283,700 | +3075.2% | 0.03% | – |
| Q4 2021 | $262,000 | -88.0% | 8,935 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $2,175,000 | +22.5% | 85,361 | +68.4% | 0.00% | +50.0% |
| Q2 2021 | $1,775,000 | -44.2% | 50,680 | +0.6% | 0.00% | -33.3% |
| Q2 2020 | $3,182,000 | +668.6% | 50,400 | +522.2% | 0.00% | – |
| Q1 2020 | $414,000 | -98.9% | 8,100 | -99.0% | 0.00% | -100.0% |
| Q2 2018 | $39,390,000 | +33.3% | 829,500 | +35.6% | 0.02% | -31.2% |
| Q1 2018 | $29,550,000 | +410.5% | 611,800 | +228.2% | 0.03% | +357.1% |
| Q3 2017 | $5,788,000 | +148.1% | 186,400 | +84.2% | 0.01% | +75.0% |
| Q3 2016 | $2,333,000 | – | 101,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |